Tom Gilbert, Associate Professor of Chemistry and Chemical Biology, is one of two people vying to be president of the world’s largest scientific professional society.
As the Zika virus continues its inexorable spread, a panel of faculty members discussed how they—and by extension we—can be part of the global solution.
Northeastern research professor K.M. Abraham goes inside the self-balancing scooters to reveal the science behind their combustion.
Scientists and researchers. Educators and future doctors. These were the people behind NU Talk 2016.
Alexandros Makriyannis, George D. Behrakis Endowed Chair at Northeastern and Founder and Director of the Center for Drug Discovery, has received the American Association of Pharmaceutical Scientists Distinguished Pharmaceutical Scientist Award for 2015. This award is part of a long line of accomplishments for Makriyannis, who has published over 500 papers and has over 50 patents in the field of medicinal chemistry.
The seventh row of the periodic table is now complete after Monday’s announcement of four new elements. Chemistry professor Michael Pollastri explains why this is an important milestone for science.
Two professors – one from the biology department and the other from the chemistry and chemical biology department – have been awarded more than a half-million dollars to investigate the production of cancer drugs in Catharanthus roseus.
Thirty students took part in NU-CD4. The course focused on the drug development process and gave the students the opportunity both to visit world-leading institutions in pharmaceutical research and manufacturing and conduct a research project focusing on identifying problems with existing drugs and developing novel remedies for those problems.
Professor Matthias Mann, Director in the Department of Proteomics and Signal Transduction at the Max Planck Institute of Biochemistry in Munich, Germany, was the recipient the Inaugural Barry L. Karger Medal in Bioanalysis.
James Aggen, a professor in the College of Science and Bouve College of Health Sciences, describes his to work to develop antidotes for multidrug-resistant (MDR) Gram-negative bacterial infections.